CBER/CDER Consolidation Receives McClellan’s Blessing; Tensions Continue

Incoming Commissioner Mark McClellan, MD/PhD, is indicating strong support of the shift of biological product reviews from the Center for Biologics Evaluation & Research to the Center for Drug Evaluation & Research